World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
76
Citations
24688
World Ranking
1877
National Ranking
916

Michael Piatak publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michael Piatak sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 197 publications — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Michael Piatak D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michael Piatak sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 76 D-Index — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Michael Piatak is affiliated with Leidos in the United States. Their research primarily covers areas within Immunology and Microbiology as well as Medicine. Specific subfields of study include Virology, Immunology, Epidemiology, and Cell Biology.

The scientist's work focuses on several key topics, including:

  • HIV Research and Treatment
  • Virology and Viral Diseases
  • Immune Cell Function and Interaction
  • Interferon and Immune Responses
  • Herpesvirus Infections and Treatments
  • Cellular Transport and Secretion
  • Immune Responses and Vaccinations

Michael Piatak has authored multiple papers, with recent publications spanning from 2020 to 2022. The following are notable examples along with their year of publication and the venues in which they appeared:

  • "IFN-α blockade during ART-treated SIV infection lowers tissue vDNA, rescues immune function, and improves overall health," 2022, JCI Insight
  • "A cellular trafficking signal in the SIV envelope protein cytoplasmic domain is strongly selected for in pathogenic infection," 2022, PLoS Pathogens
  • "A tyrosine-based trafficking signal in the simian immunodeficiency virus envelope cytoplasmic domain is strongly selected for in pathogenic SIV infection," 2021, bioRxiv (Cold Spring Harbor Laboratory)
  • "Vaccine-Elicited Mucosal and Systemic Antibody Responses Are Associated with Reduced Simian Immunodeficiency Viremia in Infant Rhesus Macaques," 2020, UNC Libraries

The venues in which Michael Piatak has published their research include:

  • JCI Insight
  • PLoS Pathogens
  • bioRxiv (Cold Spring Harbor Laboratory)
  • UNC Libraries

The scientist collaborates frequently with several co-authors, which include:

  • Jeffrey D. Lifson
  • Scott P. Lawrence
  • Samra E. Elser
  • Workineh Torben
  • Robert V. Blair

Best Publications

  • Molecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible Agent

    Jeff Linnen;John Wages;Zhen-Yong Zhang-Keck;Kirk E. Fry

  • High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR

    Piatak M;Saag Ms;Yang Lc;Clark Sj

  • Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine

    Scott G. Hansen;Julia C. Ford;Matthew S. Lewis;Abigail B. Ventura

  • Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge

    Scott G Hansen;Cassandra Vieville;Nathan Whizin;Lia Coyne-Johnson

  • Immune clearance of highly pathogenic SIV infection

    Scott G. Hansen;Michael Piatak;Abigail B. Ventura;Colette M. Hughes

  • Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant

    Deborah Persaud;Carrie Ziemniak;Ya Hui Chen

  • Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia

    Masashi Shingai;Yoshiaki Nishimura;Florian Klein;Hugo Mouquet

  • B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers.

    Yoshinori Fukazawa;Richard Lum;Afam A Okoye;Haesun Park

  • Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells

    Stuart G. Turville;John J. Santos;Ines Frank;Paul U. Cameron

  • Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species

    M. Piatak;Ka-Cheung Luk;B. Williams;J. D. Lifson

  • Prevention of Vaginal SHIV Transmission in Rhesus Macaques Through Inhibition of CCR5

    Michael M Lederman;Ronald S Veazey;Robin Ewart Offord;Donald E Mosier

  • Reversion of CTL escape-variant immunodeficiency viruses in vivo.

    Thomas C Friedrich;Elizabeth J Dodds;Levi J Yant;Lara Vojnov

  • Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara.

    V M Hirsch;T R Fuerst;G Sutter;M W Carroll

  • Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS.

    A. Nichole Cline;Julian W. Bess;Michael Jr Piatak;Jeffrey D. Lifson

  • Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo

    Francesco R. Simonetti;Michele D. Sobolewski;Elizabeth Fyne;Wei Shao

  • Insufficient Production and Tissue Delivery of CD4+Memory T Cells in Rapidly Progressive Simian Immunodeficiency Virus Infection

    Louis J. Picker;Shoko I. Hagen;Richard Lum;Edward F. Reed-Inderbitzin

  • AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges

    Matthew R. Gardner;Lisa M. Kattenhorn;Hema R. Kondur;Markus von Schaewen

  • Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy

    Anthony R. Cillo;Michele D. Sobolewski;Ronald J. Bosch;Elizabeth Fyne

  • Protective Efficacy of Adenovirus/Protein Vaccines Against SIV Challenges in Rhesus Monkeys

    Dan H. Barouch;Dan H. Barouch;Galit Alter;Thomas Broge;Caitlyn Linde

  • Defining HIV and SIV Reservoirs in Lymphoid Tissues.

    Claire Deleage;Stephen W. Wietgrefe;Gregory Del Prete;David R. Morcock

  • Progressive CD4+ central–memory T cell decline results in CD4+ effector–memory insufficiency and overt disease in chronic SIV infection

    Afam A. Okoye;Martin Meier-Schellersheim;Jason M. Brenchley;Shoko I Hagen

  • Role of CD8+ Lymphocytes in Control of Simian Immunodeficiency Virus Infection and Resistance to Rechallenge after Transient Early Antiretroviral Treatment

    Jeffrey D. Lifson;Jeffrey L. Rossio;Michael Piatak;Thomas Parks

Frequent Co-Authors

Jeffrey D. Lifson
Jeffrey D. Lifson Leidos (United States)
Agegnehu Gettie
Agegnehu Gettie Aaron Diamond AIDS Research Center
Louis J. Picker
Louis J. Picker Oregon Health & Science University
Michael K. Axthelm
Michael K. Axthelm Oregon National Primate Research Center
James Blanchard
James Blanchard Tulane University
R. Paul Johnson
R. Paul Johnson Emory University
Ronald S. Veazey
Ronald S. Veazey Tulane University
Ronald C. Desrosiers
Ronald C. Desrosiers University of Miami
Brandon F. Keele
Brandon F. Keele National Institutes of Health
Jay A. Nelson
Jay A. Nelson Oregon Health & Science University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring health-related online degrees can offer diverse career opportunities. Many students pivot from immunology to nursing fields, where foundational biological knowledge is highly valued. Programs like the best online rn programs for non nurses provide a streamlined path for individuals without a prior nursing background to enter this essential healthcare profession.

Accelerated routes, such as the 12-month accelerated nursing programs, are designed for those eager to quickly transition into clinical roles. These programs demand commitment but significantly shorten the timeline to becoming a Registered Nurse (RN), a role closely linked to immunological patient care and research.

For students seeking more accessible entry points, lpn schools easy to get into offer foundational training in nursing, often requiring less time and allowing for practical experience in healthcare settings that intersect with immunology.

Advancing further, the easiest np program options provide pathways to becoming a Nurse Practitioner, enabling professionals to specialize in areas like immunology for patient diagnosis and treatment. These degree pathways collectively illustrate a flexible and comprehensive approach to careers related to immunology in the USA.

Best Scientists Citing Michael Piatak

Trending Scientists

Recently Published Articles